IYH — iShares U.S. Healthcare ETF
Healthcare Ranked #205 of 458 tracked ETFs · Issued by iShares
IYH Price Performance — Growth of $10,000
Value of a $10,000 investment in IYH over time, compared with SPY. Both lines are rebased to $10,000 on the first shared date. Based on total returns — prices are adjusted for dividends and splits, so this assumes distributions were reinvested. Hover or tap the chart for exact values.
IYH Drawdown
The "underwater" chart: IYH's decline from its highest prior value at each point in time. It shows how deep past losses ran and how long the fund took to recover to break-even.
What If You'd Invested in IYH?
See what a lump sum in IYH would have grown to, with the option to add a regular monthly contribution on top. Figures use total returns — dividends are assumed reinvested.
Past performance doesn't predict future results. Assumes contributions on the first trading day of each month, no trading costs or taxes, and reinvested distributions. History is limited to the range published in the site's daily return data.
Overview
The iShares U.S. Healthcare ETF (IYH) is an iShares-managed fund with $3.86 billion in assets, currently holding a C grade (62.8/100). It ranks 8th out of 11 peers in the Healthcare category and 205th of 458 tracked ETFs overall. The fund charges an expense ratio of 0.37%, slightly above the category median of 0.36%. Its dividend yield of 4.02% significantly exceeds the category median of 0.88%. The top ten holdings represent 57.4% of assets, with Eli Lilly and Company comprising the largest single position at 13.7%.
IYH has delivered a one-year return of +22.95%, trailing the category median of +24.59%. Short-term momentum shows a divergence, with a 1-day loss of -2.40% contrasting against a 3-month gain of +10.58%. The fund’s price of $70.66 sits at 78.3% of its 52-week range. This performance profile coincided with a rating downgrade from B to C on 2026-09-08. Historical data is limited, with price history available for only 3.0 years.
The fund exhibits a beta of 0.54, indicating it moves less than the broader market. Annualized volatility stands at 16.24%, which is labeled as Moderate. A Sharpe ratio of 1.11 suggests favorable risk-adjusted returns relative to the risk taken. Maximum drawdown has reached -17.91%, reflecting significant historical downside. Liquidity is supported by an average daily volume of 684,040 shares, though the bid/ask spread is 1.71%.
AI-generated summary based on the data on this page.
IYH Top Holdings
| # | Holding | % of Net Assets | Value |
|---|---|---|---|
| 1 | ELI LILLY AND COMPANY | 13.72% | $385M |
| 2 | JOHNSON & JOHNSON | 10.14% | $284M |
| 3 | ABBVIE INC. | 6.86% | $192M |
| 4 | UNITEDHEALTH GROUP INCORPORATED | 6.18% | $173M |
| 5 | MERCK & CO., INC. | 4.97% | $139M |
| 6 | AMGEN INC. | 3.41% | $96M |
| 7 | THERMO FISHER SCIENTIFIC INCORPORATED | 3.32% | $93M |
| 8 | GILEAD SCIENCES, INC. | 2.99% | $84M |
| 9 | INTUITIVE SURGICAL, INC. | 2.96% | $83M |
| 10 | ABBOTT LABORATORIES | 2.88% | $81M |
Holdings as of 2026-04-30 per the fund's most recent SEC N-PORT-P filing. Top 10 holdings make up 57.4% of net assets — a rough gauge of concentration risk (the higher this figure, the more the fund's return depends on a handful of names). To see how IYH's holdings overlap with other ETFs you own or are considering, check the Stock Overlap tool.
Which Funds Overlap With IYH
Holding two funds that own the same companies adds cost and complexity without adding much diversification. These tracked ETFs share the most names with IYH's top 10 — XLV overlaps most, holding 9 of the same companies as IYH's top 10 (43.7% of IYH's assets).
| ETF | Name | Shared Companies | IYH Weight | Examples |
|---|---|---|---|---|
| XLV | State Street Health Care Select Sector SPDR ETF | 9 | 43.7% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED… |
| FHLC | Fidelity MSCI Health Care Index ETF | 9 | 43.7% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED… |
| VHT | Vanguard Health Care Index Fund ETF Shares | 8 | 40.8% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED… |
| VTV | Vanguard Morningstar Value ETF | 3 | 23.2% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED |
| DGRO | iShares Core Dividend Growth ETF | 3 | 23.2% | JOHNSON & JOHNSON, ABBVIE INC., UNITEDHEALTH GROUP INCORPORATED |
Compares the top 10 reported holdings of each fund, so it's a floor on true overlap — two S&P 500 trackers overlap ~100% even when only 10 names are listed. Use the Stock Overlap tool to search by individual company.
Market Backdrop
10-Year Treasury Yield: 4.78% (as of 2026-09-04) — The yield on 10-year US Treasury bonds — the standard "risk-free rate" benchmark used to contextualize this fund’s Sharpe ratio and returns.
CBOE Volatility Index (VIX): 15.30 (as of 2026-09-07) — A real-time gauge of expected S&P 500 volatility over the next 30 days — useful context for this fund’s own volatility label.
Federal Funds Rate: 3.63% (as of 2026-08-01) — The Federal Reserve’s target policy rate, which anchors short-term borrowing costs across the economy.
What IYH's Fees Cost You
IYH charges an expense ratio of 0.37% a year, deducted automatically from the fund's value. Small percentages compound into real money — adjust the figures below to see the impact on your own numbers.
Assumes a constant gross return and no additional contributions — a simplification, but it isolates exactly what the expense ratio costs. Try the full fee calculator to model contributions and compare any two funds.
IYH Dividend Income Estimator
IYH currently yields 4.02%. Enter an amount to see the income that implies, or set a monthly income target to see the investment it would take.
Based on the fund's current trailing yield, which varies with price and distributions — treat it as an estimate, not a guarantee. Yields are not adjusted for tax.
IYH Liquidity, Domicile & Tax Treatment
Liquidity: Quoted bid/ask spread is 1.71% and average daily volume is 684K/day. Tighter spreads and higher volume mean lower round-trip trading costs; this is a live-market snapshot and can widen during volatile sessions. AUM of $3.86B provides ample scale, supporting tight spreads and issuer commitment to keep the fund open.
Domicile & tax treatment: IYH is a US-domiciled, SEC-registered ('40 Act) exchange-traded fund. Dividends and capital gains distributions are reported to US investors on Form 1099-DIV, and the fund is not subject to the PFIC reporting or UCITS-specific rules that apply to Irish- or Luxembourg-domiciled funds. Non-US investors should note that US-domiciled ETFs are generally subject to 30% US withholding tax on dividends (unless reduced by treaty) and to US estate tax exposure on the position — Irish-domiciled UCITS ETFs tracking the same index often avoid both, which is why non-US residents frequently prefer the UCITS equivalent where one exists. This is general information, not tax advice — consult a tax professional for your situation.
IYH Performance History
| Period | Return |
|---|---|
| 1-Day | -2.40% |
| 1-Week | -1.89% |
| 1-Month | +0.94% |
| 3-Month | +10.58% |
| 6-Month | +10.25% |
| YTD | +8.72% |
| 1-Year | +22.95% |
| 3-Year | +31.02% |
How IYH Compares to Other Healthcare ETFs
| Rank | Grade | Ticker | Name | 1-Year | Exp. Ratio | AUM |
|---|---|---|---|---|---|---|
| #63 | B |
XBI | State Street SPDR S&P Biotech ETF | +70.39% | 0.35% | $11.4B |
| #87 | B |
VHT | Vanguard Health Care Index Fund ETF Shares | +24.53% | 0.09% | $22.0B |
| #98 | B |
XLV | State Street Health Care Select Sector SPDR ETF | +23.31% | 0.08% | $43.9B |
| #108 | B |
IBB | iShares Biotechnology ETF | +45.23% | 0.44% | $10.5B |
| #122 | B |
FHLC | Fidelity MSCI Health Care Index ETF | +24.59% | 0.084% | $3.48B |
| #150 | B |
XPH | State Street SPDR S&P Pharmaceuticals ETF | +48.02% | 0.35% | $587M |
| #203 | C |
PPH | VanEck Pharmaceutical ETF | +26.70% | 0.36% | $1.03B |
| #205 | C |
IYH | iShares U.S. Healthcare ETF | +22.95% | 0.37% | $3.86B |
| #240 | C |
ARKG | ARK Genomic Revolution ETF | +83.58% | 0.75% | $2.02B |
| #393 | C |
IHF | iShares U.S. Healthcare Providers ETF | +20.58% | 0.37% | $1.23B |
| #443 | F |
IHI | iShares U.S. Medical Devices ETF | -16.78% | 0.37% | $3.47B |